Clearance of erythrocyte allo-antibodies using Rituximab

MeSH terms

• Agglutinins / biosynthesis
• Agglutinins / blood*
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• B-Lymphocyte Subsets / drug effects
• B-Lymphocyte Subsets / immunology
• Blood Group Antigens / immunology*
• Cryoglobulins
• Erythrocyte Membrane / immunology*
• Erythrocyte Transfusion / adverse effects
• Fatal Outcome
• Fetal Blood / cytology
• Gastrointestinal Hemorrhage / therapy
• Hematopoietic Stem Cell Transplantation
• Humans
• Interferons / adverse effects
• Interferons / therapeutic use
• Isoantibodies / biosynthesis
• Isoantibodies / blood*
• Kell Blood-Group System / immunology
• Male
• Middle Aged
• Primary Myelofibrosis / immunology
• Primary Myelofibrosis / therapy*
• Rituximab
• Systemic Inflammatory Response Syndrome / complications